NO20085213L - Nye pyridinanaloger - Google Patents
Nye pyridinanalogerInfo
- Publication number
- NO20085213L NO20085213L NO20085213A NO20085213A NO20085213L NO 20085213 L NO20085213 L NO 20085213L NO 20085213 A NO20085213 A NO 20085213A NO 20085213 A NO20085213 A NO 20085213A NO 20085213 L NO20085213 L NO 20085213L
- Authority
- NO
- Norway
- Prior art keywords
- new pyridine
- pyridine analogs
- formula
- analogs
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår visse nye pyridinanaloger med formel ( I ) Formel ( I ) til prosesser for fremstilling av slike forbindelser, til deres nytte som P2Y12 inhibitorer og som anti-trombotiske midler etc, anvendelse av dem som medikamenter i kardiovaskulære sykdommer så vel som farmasøytiske preparater inneholdende dem.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601465 | 2006-07-04 | ||
PCT/SE2007/000641 WO2008004941A1 (en) | 2006-07-04 | 2007-07-02 | New pyridine analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085213L true NO20085213L (no) | 2009-01-13 |
Family
ID=38894820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085213A NO20085213L (no) | 2006-07-04 | 2008-12-15 | Nye pyridinanaloger |
Country Status (13)
Country | Link |
---|---|
US (2) | US20090312368A1 (no) |
EP (1) | EP2041112A1 (no) |
JP (1) | JP2009542641A (no) |
KR (1) | KR20090031605A (no) |
CN (1) | CN101506193A (no) |
AU (1) | AU2007270081A1 (no) |
BR (1) | BRPI0713401A2 (no) |
CA (1) | CA2655628A1 (no) |
IL (1) | IL195979A0 (no) |
MX (1) | MX2008016551A (no) |
NO (1) | NO20085213L (no) |
WO (1) | WO2008004941A1 (no) |
ZA (1) | ZA200810647B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070107024A (ko) * | 2005-01-06 | 2007-11-06 | 아스트라제네카 아베 | 신규 피리딘 화합물 |
AU2006267148A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
TW200811133A (en) * | 2006-07-04 | 2008-03-01 | Astrazeneca Ab | New pyridine analogues III 334 |
EP2044024A4 (en) * | 2006-07-04 | 2011-06-29 | Astrazeneca Ab | NEW ANALOGUES OF PYRIDINE |
WO2008004941A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | New pyridine analogues |
US20110059981A9 (en) * | 2006-07-04 | 2011-03-10 | Astrazeneca Ab | New Pyridine Analogues V |
US20080171732A1 (en) * | 2007-01-12 | 2008-07-17 | Astrazeneca Ab | New Pyridine Analogues IX 519 |
US20080176827A1 (en) * | 2007-01-12 | 2008-07-24 | Astrazeneca Ab | New Pyridine Analogues VII 543 |
US20090018166A1 (en) * | 2007-07-13 | 2009-01-15 | Astrazeneca Ab | New Pyridine Analogues X 161 |
WO2010005385A1 (en) * | 2008-07-07 | 2010-01-14 | Astrazeneca Ab | 2-amino-6-alkyl substituted pyridine derivatives useful as p2y12 inhibitors 308 |
US9539246B2 (en) | 2011-08-30 | 2017-01-10 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
EP1257550B1 (en) * | 2000-02-04 | 2005-11-16 | Portola Pharmaceuticals, Inc. | Platelet adp receptor inhibitors |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
FR2820057A1 (fr) * | 2001-01-30 | 2002-08-02 | Ct De Transfert De Technologie | Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane |
US7790736B2 (en) * | 2003-08-13 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CA2539882A1 (en) * | 2003-10-03 | 2005-04-21 | Portola Pharmaceuticals, Inc. | Substituted isoquinolinones |
US7335648B2 (en) * | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
US7504497B2 (en) * | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
NZ551603A (en) * | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
KR20070107024A (ko) * | 2005-01-06 | 2007-11-06 | 아스트라제네카 아베 | 신규 피리딘 화합물 |
AU2006267148A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
WO2008004941A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | New pyridine analogues |
EP2044024A4 (en) * | 2006-07-04 | 2011-06-29 | Astrazeneca Ab | NEW ANALOGUES OF PYRIDINE |
US20110059981A9 (en) * | 2006-07-04 | 2011-03-10 | Astrazeneca Ab | New Pyridine Analogues V |
TW200811133A (en) * | 2006-07-04 | 2008-03-01 | Astrazeneca Ab | New pyridine analogues III 334 |
US20080200448A1 (en) * | 2007-01-12 | 2008-08-21 | Astrazeneca Ab | New Pyridine Analogues VIII 518 |
US20080176827A1 (en) * | 2007-01-12 | 2008-07-24 | Astrazeneca Ab | New Pyridine Analogues VII 543 |
US20080171732A1 (en) * | 2007-01-12 | 2008-07-17 | Astrazeneca Ab | New Pyridine Analogues IX 519 |
US20090018166A1 (en) * | 2007-07-13 | 2009-01-15 | Astrazeneca Ab | New Pyridine Analogues X 161 |
-
2007
- 2007-07-02 WO PCT/SE2007/000641 patent/WO2008004941A1/en active Application Filing
- 2007-07-02 CA CA002655628A patent/CA2655628A1/en not_active Abandoned
- 2007-07-02 CN CNA200780031613XA patent/CN101506193A/zh active Pending
- 2007-07-02 US US12/307,284 patent/US20090312368A1/en not_active Abandoned
- 2007-07-02 MX MX2008016551A patent/MX2008016551A/es not_active Application Discontinuation
- 2007-07-02 JP JP2009518048A patent/JP2009542641A/ja active Pending
- 2007-07-02 KR KR1020097002236A patent/KR20090031605A/ko not_active Application Discontinuation
- 2007-07-02 US US11/772,257 patent/US20080009523A1/en not_active Abandoned
- 2007-07-02 EP EP07748300A patent/EP2041112A1/en not_active Withdrawn
- 2007-07-02 BR BRPI0713401-0A patent/BRPI0713401A2/pt not_active IP Right Cessation
- 2007-07-02 AU AU2007270081A patent/AU2007270081A1/en not_active Abandoned
-
2008
- 2008-12-15 NO NO20085213A patent/NO20085213L/no not_active Application Discontinuation
- 2008-12-16 IL IL195979A patent/IL195979A0/en unknown
- 2008-12-17 ZA ZA200810647A patent/ZA200810647B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20090312368A1 (en) | 2009-12-17 |
CN101506193A (zh) | 2009-08-12 |
BRPI0713401A2 (pt) | 2012-04-17 |
MX2008016551A (es) | 2009-02-06 |
JP2009542641A (ja) | 2009-12-03 |
EP2041112A1 (en) | 2009-04-01 |
KR20090031605A (ko) | 2009-03-26 |
CA2655628A1 (en) | 2008-01-10 |
IL195979A0 (en) | 2009-09-01 |
WO2008004941A1 (en) | 2008-01-10 |
ZA200810647B (en) | 2009-12-30 |
AU2007270081A1 (en) | 2008-01-10 |
US20080009523A1 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085218L (no) | Nye pyridinanaloger | |
NO20085213L (no) | Nye pyridinanaloger | |
NO20073101L (no) | Nye pyridinforbindelser | |
NO20085214L (no) | Nye pyridinanaloger | |
NO20076682L (no) | Nye pyridinanaloger | |
NO20085212L (no) | Nye pyridinanaloger | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
NO20071246L (no) | Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer. | |
NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
NO20070339L (no) | 1-aza-bicyklo[3 3.1]nonaner | |
NO20071245L (no) | Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer. | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
PH12014501134B1 (en) | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication | |
NO20090628L (no) | Pyridizinon derivativater | |
NO20082709L (no) | Kjemiske forbindelser | |
EP1982982A4 (en) | NEW COUMARINE DERIVATIVE WITH ANTITUM EFFECT | |
TNSN07075A1 (en) | Pyrimidine derivatives | |
TW200732323A (en) | Organic compounds | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20071074L (no) | Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
NO20091683L (no) | Kjemiske forbindelser | |
NO20084352L (no) | Dimerer av artemisininderivater, fremstilling derav og terapeutisk anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |